
About Evotech-Mirai Genomics
Evotech-Mirai Genomics is a Healthcare company based in Kazan (Russia) founded in 2020. Genetic testing systems for Covid-19 detection are developed. Its focus areas include Life Sciences, Clinical Genomics, Amplification Based and Isothermal Amplification.
Company details
Evotech-Mirai Genomics was founded in 2020 in Kazan, Russia, within the biotechnology sector. Genetic testing systems for Covid-19 detection are developed, including the portable smartAmp device that employs isothermal amplification technology for point-of-care use. Reagents for laboratory applications are also produced. Operations center on advancing diagnostic tools for infectious disease identification in a Russian-based framework.
- Headquarters Kazan, Russia
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website evotech-mg.com
Web traffic of Evotech-Mirai Genomics
The website of Evotech-Mirai Genomics (evotech-mg.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 25.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Evotech-Mirai Genomics
Evotech-Mirai Genomics was founded in 2020.
Evotech-Mirai Genomics is headquartered in Kazan, Russia. It is registered at Kazan, Tatarstan, Russia.
Evotech-Mirai Genomics was founded in 2020 in Kazan, Russia, within the biotechnology sector. Genetic testing systems for Covid-19 detection are developed, including the portable smartAmp device that employs isothermal amplification technology for point-of-care use. Reagents for laboratory applications are also produced. Operations center on advancing diagnostic tools for infectious disease identification in a Russian-based framework.